Sign in
4

Changes in Ownership

Silence Therapeutics plc Filed Acc 0001415889-25-000743

Options or other derivatives

  • President and CEO acquired 900,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

TOOMAN CRAIG A · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-02 Grant or award : show line 1 in the form Employee Share Option (Right to Buy) +900,000 900,000 D
Loading xslF345X05/form4-01062025_040101.xml…